Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 576 of 1,261
  1. US 9920378

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  2. US 9920085

    Boronic acid conjugates of oligonucleotide analogues

    Sarepta Therapeutics, Inc. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  3. US 9920068

    Pyridine compounds

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  4. US 9920041

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  5. US 9920047

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  6. US 9920033

    Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  7. US 9919063

    Multi-encapsulated formulations made with oxidized cellulose

    Covidien LP · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  8. US 9919058

    Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  9. US 9919065

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  10. US 9919055

    Sugar-linker-drug conjugates

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  11. US 9919051

    Liquid formulation comprising GM-CSF neutralizing compound

    TAKEDA GMBH · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  12. US 9918989

    Combination therapies for malaria

    The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  13. US 9919008

    Method for treating age-related hearing loss (ARHL)

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  14. US 9919027

    Lipid nanoparticle of polymyxin

    UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  15. US 9918986

    Methods and compounds for preventing osteoarthritis

    University College Cardiff Consultants Limited · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  16. US 9918939

    Formulation of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  17. US 9918959

    TLR-independent small molecule adjuvants

    The Board of Regents of the University of Texas System · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  18. US 9918948

    Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine

    TONIX PHARMA LIMITED · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  19. US 9920109

    Serpin fusion polypeptides and methods of purification thereof

    Inhibrx, Inc. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  20. US 9918968

    Rapamycin analogs targeting proteasome function in the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  21. US 9921223

    Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis

    The Board of Regents of the University of Texas System · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  22. US 9920321

    Compositions and their uses directed to huntingtin

    Ionis Pharmaceuticals, Inc. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  23. US 9920100

    Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy

    The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  24. US 9918983

    Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.